GWD-23-Q1 B为什么不可以呢？

rock19840717 · 发表于 2008-10-4 10:34:00

A major health insurance company in Lagolia pays for special procedures prescribed by physicians only if the procedure is first approved as “medically necessary” by a company-appointed review panel. The rule is intended to save the company the money it might otherwise spend on medically unnecessary procedures. The company has recently announced that in order to reduce its costs, it will abandon this rule.

Which of the following, if true, provides the strongest justification for the company’s decision?

A. Patients often register dissatisfaction with physicians who prescribe nothing for their ailments.

B. Physicians often prescribe special procedures that are helpful but not altogether necessary for the health of the patient.

C. The review process is expensive and practically always results in approval of the prescribed procedure.

D. The company’s review process does not interfere with the prerogative of physicians, in cases where more than one effective procedure is available, to select the one they personally prefer.

E. The number of members of the company-appointed review panel who review a given procedure depends on the cost of the procedure.

看到B觉得就是答案了，再看到C，立刻昏倒，无法排除B，我理解了下，就算B这样的情况的话，还是可以节省一些不必要的procedures？

rock19840717 · 发表于 2008-10-6 11:09:00

无限顶

AlienX · 发表于 2008-10-6 14:23:00

umm...GMAC的CR思路一般都是要*直接*跟passage中的*推理過程*有關
B是無關
那個procedures對patients怎樣, 那個company不care, 它只關心the cost
LZ可以下個OG10的分類version, 去看看所有weaken的題就會明白=>GMAC的CR思路一般都是要*直接*跟passage中的*推理過程*有關

cissy630 · 发表于 2010-5-17 19:53:01

因为题干中说了付款的条件是if the procedure is first approved as “medically necessary” by a company-appointed review panel，而B说医生常开procedures that are helpful but not altogether necessary,既然是not necessary，这个公司自然不会付款，所以医生开不开B中所说的这类药方都与公司的利益无关。

双鱼游 · 发表于 2010-10-3 09:07:02

A. this suggests that patients might be pressuring their physicians to prescribe certain unnecessary precedures for their ailmwnts ,which in turn suggests that the panel is reviewing these procedures and debying them .but if so , then the panel is probably saving the insurance company money ,so adbandoning the panel's review would not reduce the company's costs
B this suggests that certain procedures that are being prescribed by physicians are not medically necessary ,which in turn suggest that the panel reviewing these procedures may be denying them .if this is the case,then the panel is probably saving the insurance company a significant amount of money ,so abandoning the panel's review may well increase rather than decrease the companys costs
D even if the panel does not interfere with physicians'choices when more than one medically effective procedure is available ,the panel may still be denying pay for many procedures that are not medically necessary .in such cases the panel may be saving the insurance comany money and abandoing the review process would not reduce the comoany's costs
E. this suggests that the more expensive the procedure under review ,the more expensive the panel itself is .even so ,if the panel denies payment for very expensive procedures ,it may nonetheless save the company significantly more than the company has to pay to convene the panel, so abandoing the review process would not reduce the companys' costs

双鱼游 · 发表于 2010-10-3 09:07:35

从OG second edition 上码下来的

本贴相关题目 OG-2017V-CR-122 | TN-16-CR-19OG-2017V-CR-122 |
OG-2016V-CR-18 |
OG-2015V-CR-17 |
TN-16-CR-19
... (BHND)

相关帖子

更多相关帖子

GWD-23-Q1 B为什么不可以呢？